Goldman Sachs Group Inc Icad Inc Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$2.04 - $4.32 $1,344 - $2,846	-659 Reduced 1.02%	63,876 $134,000
Q3 2022 Nov 10, 2022	SELL	$2.04 - $4.32 $1,344 - $2,846	-659 Reduced 1.02%	63,876 $0
Q2 2022 May 14, 2024	BUY	$3.02 - $4.56 $194,895 - $294,279	64,535 New	64,535 $258,000
Q2 2022 Aug 15, 2022	SELL	$3.02 - $4.56 $43,744 - $66,051	-14,485 Reduced 18.33%	64,535 $258,000
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $11,124 - $21,228	-2,838 Reduced 3.47%	79,020 $352,000
Q4 2021 Feb 14, 2022	SELL	$6.7 - $11.38 $14,518 - $24,660	-2,167 Reduced 2.58%	81,858 $589,000
Q3 2021 Nov 10, 2021	BUY	$10.11 - $17.56 $849,492 - $1.48 Million	84,025 New	84,025 $904,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $49.9M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.